Trial Profile
Effects of Ketoconazole on the Pharmacokinetics of Ponatinib in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2013
Price :
$35
*
At a glance
- Drugs Ponatinib (Primary) ; Ketoconazole
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 20 Aug 2013 New trial record
- 25 Jun 2013 Results published in the Journal of Clinical Pharmacology.